Upregulated expression of TIM-3 in tumor tissue samples has been demonstrated in melanoma, prostate cancer, colon cancer, bladder urothelial carcinoma, cervical cancer, gastric cancer, liver cancer, and lung cancer cells. This evidence concerns the gene HAVCR2 and melanoma.